SCHEMBL6563544

SCHEMBL6563544

Cc1cc(C#CCNc2ccc(C(=N)N)cc2)ccc1-n1nc(CCC(=O)O)cc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXRA P19793 5/20 0.38
RXRB P28702 5/20 0.38
RXRG P48443 5/20 0.38
ITGB3 P05106 2/20 0.36
ITGA2B P08514 2/20 0.36
FABP3 P05413 1/20 0.35
ALDH1A1 P00352 2/20 0.35
F2 P00734 6/20 0.35
NQO2 P16083 1/20 0.34
HPGD P15428 1/20 0.34
ADH5 P11766 1/20 0.34
CYP2C19 P33261 1/20 0.34
EGLN1 Q9GZT9 1/20 0.33
FFAR1 O14842 1/20 0.33
F10 P00742 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6563546 0.92 F10 (0.38) ITGB3ITGA2BALDH1A1F2NQO2
SCHEMBL6563913 0.76 CA12 (0.33) ITGB3ITGA2BF2EGLN1F10
SCHEMBL7379565 0.75 KLK1 (0.44) RXRARXRBRXRGALDH1A1F2
SCHEMBL6563277 0.72 F2 (0.41) F2EGLN1F10PRSS1
SCHEMBL6565332 0.72 RXRA (0.51) RXRARXRBRXRGFABP3ALDH1A1
SCHEMBL7416681 0.71 F2 (0.60) F2NQO2F10PRSS1PRSS2
SCHEMBL6562124 0.70 KLK5 (0.47) ALDH1A1F2HPGDCYP2C19PRSS1
SCHEMBL7383225 0.69 KLK1 (0.40) F2NQO2F10PRSS1PRSS2
SCHEMBL6563625 0.69 PRSS1 (0.43) ALDH1A1F2HPGDF10PRSS1
SCHEMBL7372469 0.68 KLK1 (0.46) ALDH1A1F2NQO2F10PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed
US-6479524-B1 TO PROLONG THE THROMBIN TIME BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-11-12 US disclosed